Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04863248 |
|---|---|
| Brief Title: | Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Docetaxel for Metastatic Non-Small Cell Lung Cancer (NSCLC) (PRESERVE 4) (PRESERVE 4) |
| First Submitted : | April 16, 2021 |
| First Submitted that Met QC Criteria : | April 23, 2021 |
| First Posted : | April 28, 2021 |
| Last Update Submitted that Met QC Criteria : | February 11, 2022 |
| Last Update Posted : | March 2, 2022 |